ロード中...
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies
Human cytomegalovirus (HCMV) is an important pathogen in transplant patients and in congenital infection. Previously, we demonstrated that vaccination with a recombinant viral glycoprotein B (gB)/MF59 adjuvant formulation before solid organ transplant reduced viral load parameters post transplant. R...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6004462/ https://ncbi.nlm.nih.gov/pubmed/29686064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1800224115 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|